Cart
sales@molnova.com
CDP-Star
CAS No. 160081-62-9
CDP-Star( —— )
Catalog No. M36634 CAS No. 160081-62-9
CDP-Star is a luminescent substrate for 1,2-dioxetane and a substrate for alkaline phosphatase.CDP-Star can be used for in vivo imaging by detecting mRNA on Northern blot.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 322 | In Stock |
|
| 10MG | 483 | In Stock |
|
| 25MG | 786 | In Stock |
|
| 50MG | 1051 | In Stock |
|
| 100MG | 1423 | In Stock |
|
| 200MG | 1841 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDP-Star
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDP-Star is a luminescent substrate for 1,2-dioxetane and a substrate for alkaline phosphatase.CDP-Star can be used for in vivo imaging by detecting mRNA on Northern blot.
-
DescriptionCDP-Star is a chemiluminescent substrate for alkaline phosphatase. CDP-Star can be used for enzyme-linked immunoassays.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number160081-62-9
-
Formula Weight495.2
-
Molecular FormulaC18H19Cl2Na2O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=P([O-])(OC1=CC(C2(OC)OOC23C4CC5CC3CC(C5)(C4)Cl)=CC=C1Cl)[O-].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu L, et al. Chemiluminescence of the Ce(IV)/CDP-Star System Based on the Phosphatase-like Activity of Ce(IV) Ions. ACS Omega. 2021 Feb 25;6(9):6379-6384.?
molnova catalog
related products
-
SHP099 monohydrochlo...
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
-
LMPTP INHIBITOR 1 hy...
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
CX08005
CX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
